1-1 of 1
Giovanni Piza, MD
Close
Sort by
Journal Articles

A Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone for Relapsed/Refractory Multiple Myeloma.

Donna E. Reece, MD, Giovanni Piza, MD, Suzanne Trudel, MD, Mariela Pantoja, PhD, Christine Chen, MD, Joseph R. Mikhael, MD, Vishal Kukreti, MD, Keith Stewart, MD
Journal: Blood
Blood (2006) 108 (11): 3536.
https://doi.org/10.1182/blood.V108.11.3536.3536
Published: 2006